Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11466068 Targeted immunotolerance

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Date Filed
April 24, 2020
0
Date of Patent
October 11, 2022
0
Patent Application Number
16857340
0
Patent Citations
‌
US Patent 10358477 IL-15Ralpha sushi domain—IL-15 fusion proteins
0
‌
US Patent 10376564 Interleukin-2 for treating food allergy
‌
US Patent 10428145 PD-1 binding proteins and methods of use thereof
‌
US Patent 10493148 PD-1 agonist antibodies and uses thereof
‌
US Patent 10676516 Targeted immunotolerance
‌
US Patent 10751414 Methods of treating psoriasis using PD-1 binding antibodies
‌
US Patent 10766958 Methods of treating vitiligo using PD-1 binding antibodies
‌
US Patent 10035836 Modified IL-2 variants that selectively activate regulatory T cells
0
‌
US Patent 10086046 Agent for the treatment and or prophylaxis of an autoimmune disease and for the formation of regulatory T cells
‌
US Patent 10093711 Interleukin-2 muteins for the expansion of T-regulatory cells
•••
Patent Inventor Names
Joanne L. Viney
0
Nathan Higginson-Scott
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
11466068
0
Patent Primary Examiner
‌
Prema M Mertz
0
CPC Code
‌
A61K 2039/55533
0

Find more entities like US Patent 11466068 Targeted immunotolerance

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo